Overview

* Select Medical ( SEM ) Q2 revenue grows 4.5% yr/yr, meets analyst expectations

* EPS from continuing operations rises 88.2% to $0.32

* Adjusted EBITDA for Q2 increases 0.5% to $125.4 mln

Outlook

* Select Medical ( SEM ) reaffirms 2025 revenue outlook of $5.3 bln to $5.5 bln

* Company expects 2025 Adjusted EBITDA between $510 mln and $530 mln

* Select Medical ( SEM ) forecasts 2025 EPS between $1.09 and $1.19

Result Drivers

* REHABILITATION HOSPITALS - Revenue increased 17.2% due to higher patient admissions and occupancy rates

* OUTPATIENT REHABILITATION - Revenue grew 3.8% driven by increased patient visits

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 In-line $1.34 $1.34

Revenue bln bln (6

Analysts

)

Q2 EPS $0.32

Q2 $125.40

Adjusted mln

EBITDA

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the healthcare facilities & services peer group is "buy"

* Wall Street's median 12-month price target for Select Medical Holdings Corp ( SEM ) is $21.00, about 31% above its July 30 closing price of $14.48

* The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 14 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)